The trusted source for
healthcare information and
This webinar will cover the 2017 Confidentiality of Substance Use Disorder Patient Records (42 CFR Part 2) Final Rule and the 2018 changes in the Federal Law which went to effect on February 2nd. Previously known as the Confidentiality of Drug Abuse and Alcohol Abuse Records, this rule ensures the right to privacy and confidentiality of patients receiving treatment for a substance use disorder. This webinar will explain the mandated changes under 42 CFR Part 2 and discuss regulations with which treatment facilities must comply.
Our speaker will also discuss 2018 revisions, including ways the protected health records (PHI) on substance use disorder patients can be shared, when information can be used for audits and evaluations, and much more. Don’t miss out on this must-attend program for any substance treatment providers receiving federal assistance.
Anyone working in treatment facilities, including but not limited to: CEOs, CFOs, COOs, CMOs, CNOs, Program Directors, Risk Managers, Health Information Management Directors, Nurses (all level), Physicians, Clinicians, Hospital Legal Counselors, Compliance Officers, and anyone providing care and treatment to patients who have a substance use disorder.
|- History of Confidentiality of Drug and Alcohol Records||- American Hospital Association recommendations|
|- Patient access to medical records||- Prohibitions on re-disclosure|
|- Substance use disorder data||- Confidentiality requirements|
|- General provisions||- Disclosures to the criminal justice system|
|- OCR, HIPAA, and mental health records||- Medical emergencies|
|- Reports of violations & penalties||- Security of medical records|
|- Child abuse reports||- Disclosure with or without consent|
|- Minor & deceased patients||- Sub-regulatory guidance|
|- Crimes on the premise||And so much more!|
Your order includes: